Ebronucimab (Anti-PCSK9)
Product Specifications
CAS Number
2304800-90-4
Synonyms
AK102
Target
PCSK9
Applications
Metabolism
Additionnal Information
Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1218095-01 0.02 mg (E-Coli)
Recombinant Salmonella heidelberg SsrA-binding protein (smpB)
Sign In for Pricing
View Details MBS1218095-02 0.1 mg (E-Coli)
Recombinant Salmonella heidelberg SsrA-binding protein (smpB)
Sign In for Pricing
View Details MBS1218095-03 0.02 mg (Yeast)
Recombinant Salmonella heidelberg SsrA-binding protein (smpB)
Sign In for Pricing
View Details MBS1218095-04 0.1 mg (Yeast)
Recombinant Salmonella heidelberg SsrA-binding protein (smpB)
Sign In for Pricing
View Details MBS1218095-05 0.02 mg (Baculovirus)
Recombinant Salmonella heidelberg SsrA-binding protein (smpB)
Sign In for Pricing
View Details